Patents
Sitemap › C07 - Organic chemistry › C07F - Acyclic, carbocyclic, or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium › C07F 9 - Compounds containing elements of the 5th group of the periodic system
Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377)
03/2007
03/15/2007WO2007010016A3 Bisphosphines
03/15/2007WO2006115644A3 Processes for recovery of a triarylphosphine from a group viii metal catalyst complex mixture
03/15/2007US20070060772 Phosphines, transition metal complexes containing the same as the ligand, and process for production of optically active carboxylic acids
03/15/2007US20070060766 As hydrocyanation catalyst; enables in a simple and economic manner, the hydrocyanation of unsaturated organic compounds with high stability, high reactivity and high selectivity of the catalyst
03/15/2007US20070060739 Process for producing phosphonitrilic acid ester
03/15/2007US20070060536 Novel reagent compounds and methods of making and using the same
03/15/2007US20070060502 Substituted propane phosphinic acid derivatives
03/15/2007US20070056468 Process for the preparation of high-purity zirconium, hafnium, tantalum and niobium alkoxides
03/14/2007EP1762573A1 A process for the preparation of fosfomycin salts
03/14/2007EP1762572A1 Process for preparing ortho-substituted phenylphosphine ligands
03/14/2007EP1762567A1 Pyrazole derivatives for treating HIV
03/14/2007EP1761571A1 Transition metal compound, ligand system., catalyst system and process for preparing polyolefins
03/14/2007EP1761549A1 Process for the preparation of asymmetrically substituted biaryldiphosphines
03/14/2007EP1761548A1 Process for the preparation of asymmetrically substituted biaryldiphosphines
03/14/2007EP1761547A2 Compounds for organic electronic devices
03/14/2007EP1761495A2 Piperidinyl prostaglandin analogs as ocular hypotensive agents
03/14/2007EP1572621A4 Cyclohexane derivatives and methods for their preparation
03/14/2007EP1517895B1 8-(biaryl) quinoline pde4 inhibitors
03/14/2007EP1387891B1 Compounds and methods for inhibiting axillary malodour
03/14/2007EP1363921B1 Process for the preparation of dicyclohexylchlorophosphine
03/14/2007EP1286937B1 Chiral monophosphites as ligands for asymetrical hdrogenation
03/14/2007EP1040103B1 Anilide derivative, production and use thereof
03/14/2007CN1930177A Liquid textile-pretreating agent
03/14/2007CN1930176A Phosphoric acid esters and their use as wetting and dispersing agent
03/14/2007CN1930175A Compositions for treating and/or preventing diseases characterized by the presence of metal ions
03/14/2007CN1927868A Method of preparing amidophosphoric acid flame resisting agent
03/14/2007CN1927446A Pipe type continuously reacting apparatus
03/14/2007CN1304403C Monophosphine ligand having C2 symmetric skeleton, synthesis method and application
03/14/2007CN1304402C Process for treating cglyphosate mother liquor
03/14/2007CN1304401C Method for preparing Alendronic acid
03/14/2007CN1304400C Diphosphonic acid derivative, radioactive 99mTc labeled diphosphonic acid derivative and uses thereof
03/14/2007CN1304399C Continuous process for preparing n-phosphonomethyl glycine
03/14/2007CN1304398C Supercritical CO2 extraction process for soya bean lecithin
03/13/2007US7189418 Method for extracting lipid mixture containing phospholipids comprising polyunsaturated fatty acids from viscera of fish, method for preserving viscera prior to extraction, and lipid mixture extracted thereby
03/13/2007CA2264063C Cryptophycin compounds
03/08/2007WO2007027959A1 Novel benzopyran derivatives as potassium channel openers
03/08/2007WO2007026490A1 Palladium complex, process for producing the same, catalyst, and reaction method
03/08/2007WO2007026441A1 Novel optically active organophosphorus compounds, transition metal complexes containing the compounds as the ligand, and process for production of optically active compounds with the complexes
03/08/2007WO2007026379A2 Novel crystalline forms of risedronate monosodium
03/08/2007WO2007003782A3 Novel functionalised transfer agents for controlled radical polymerisation raft, raft methods using said transfer agents and polymers obtainable thereby
03/08/2007WO2006127893A3 Processes for production of 4-(biphenylyl)azetidin-2-one phosphonic acids
03/08/2007WO2006110157A9 Nucleoside phosphonate conjugates as anti hiv agents
03/08/2007WO2006090289A8 Compounds for reducing aggregation of amyloid beta-peptide
03/08/2007WO2006020779A3 Targeting chelants and chelates
03/08/2007US20070055060 For the production of solar cells and molecular memory devices; Zn(II)-5-[4-(Di-tert-butyloxyphosphoryl)phenyl]-10,20-dimesityl-15-[4-[2-(trimethylsilyl)ethynyl]phenyl]porphyrin
03/08/2007US20070054996 crystal nucleating agent composition comprising 100 mass parts of a crystal nucleating agent compound represented by the following general formula (I), -50 mass parts of a lithium salt of an organic fatty acid represented by the following general formula (II), and 5-50 mass parts of a metal salt of acid
03/08/2007US20070054279 Oligonucleotides comprising a ligand tethered to a modified or non-natural nucleobase
03/08/2007DE102006041064A1 New phosphorous compound useful as ligand in catalyst for e.g. hydroformylation-, hydrocyanation-, carbonylation-, hydroacylation-, hydroamination- and hydro esterification reactions
03/08/2007CA2620894A1 Novel benzopyran derivatives as potassium channel openers
03/07/2007EP1760769A1 Dry etching gases and method of dry etching
03/07/2007EP1760086A2 Single site palladium catalyst complexes
03/07/2007EP1759761A1 Affinity particle and affinity separation method
03/07/2007EP1759410A2 Organometallic precursor compounds
03/07/2007EP1758915A2 Composition and method for inhibiting platelet aggregation
03/07/2007EP1758903A1 Pyrrolopyramidine and pyrrolopyridine derivatives substituted with a cyclic amino group as crf antagonists
03/07/2007EP1758845A2 Preparation of aminophosphines
03/07/2007EP1758844A1 Phosphine-phosphoramidite compounds
03/07/2007EP1758595A2 Use of lipid conjugates in the treatment of diseases
03/07/2007EP1257695B1 Biomolecules having multiple attachment moieties for binding to a substrate surface
03/07/2007EP1029016B1 Novel chemiluminescent labeling compounds
03/07/2007CN1926116A Method for the production of compounds with quaternary sp<2>-hybridised nitrogen atoms
03/07/2007CN1926091A Process for the carbonylation of ethylenically or acetylenically unsaturated compounds
03/07/2007CN1923836A Ligand synthesis
03/07/2007CN1923818A Irreversible inhibitors of tyrosine kinases
03/07/2007CN1923797A Pharmaceutical compounds
03/07/2007CN1303089C Crystalline form of Adefovir dipivoxil and preparing process thereof
03/06/2007US7186855 Such as 1-(((alpha-propanoyloxybutoxy)carbonyl)aminomethyl)-1-cyclohexane acetic acid; ability to cross blood brain barrier; sustained release
03/06/2007US7186853 Phosphites with tricyclodecylmethyl groups
03/06/2007US7186826 Phosphorus-containing compounds and uses thereof
03/06/2007US7186813 Biomolecules having multiple attachment moieties for binding to a substrate surface
03/06/2007US7186797 Stability in blood ; complexing using compound containing phosphate group
03/06/2007US7186784 Solubility of phosphorus carboxylic acids for fireproofing polymers
03/06/2007US7186753 nitroso derivatives of drugs such as antiinflammatory agents, antibiotics, expectorants, mucolytic agents, antidiabetics, antitumor, viricides, enzyme inhibitors bronchodilators and antiulcer agents
03/06/2007US7186745 Angiogenesis inhibitors
03/06/2007US7186738 antibiotics such as (5R)-3-[3-Fluoro-4-(3-methylisoxazol-5-yl)phenyl]-5-(1H-1,2,3-triazol-1-ylmethyl)-1,3-oxazolidin-2-one, having effective activity against both grampositive and gramnegative pathogens
03/06/2007US7186737 Inhibitors of p38
03/06/2007US7186705 silylation of O-ethyl phosphinates with hexamethyldisilazane, then introducing the 3-amino-2-hydroxypropyl moiety by reacting with epichlorohydrin and ammonia, and hydrolysis of the ethyl moiety to 3-amino-2-hydroxypropyl(benzyl or cyclohexylmethyl)phosphinic acid, used as antidepressants
03/06/2007US7186704 Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis
03/06/2007US7186703 Derivatives of branched-chain lipophilic molecules and uses thereof
03/06/2007US7186400 Multidentate aza ligands able to complex metal ions and the use thereof in diagnostics and therapy
03/06/2007CA2200986C Medicaments
03/01/2007WO2007025043A2 Seven-membered ring nucleosides
03/01/2007WO2007025031A2 Prodrugs of indanone and tetralone compounds
03/01/2007WO2007024745A2 Phosphorus-containing macrocycles
03/01/2007WO2007023814A1 Phosphonium-type ionic compounds containing amino acids as constituent ion
03/01/2007WO2007023239A1 Organometallic precursors for depositing a tantalum carbonitride or carbide film and method of depositing one such film
03/01/2007WO2006130217A3 Substituted phosphate esters of nucleoside phosphonates
03/01/2007WO2006122186A3 1,4-diphenyl-3-hydroxyalkyl-2-azetidinone derivatives for treating hypercholestrolemia
03/01/2007WO2006119713A3 Antineoplastic compounds and pharmaceutical compositions thereof
03/01/2007WO2006072002A3 Organometallic complexes
03/01/2007WO2006054182A3 Phosphoindoles as hiv inhibitors
03/01/2007WO2004105697A3 Novel lipids for transfection of nucleic acids
03/01/2007US20070049765 Process for producing semiconductor nanocrystal cores, core-shell, core-buffer-shell, and multiple layer systems in a non-coordinating solvent utilizing in situ surfactant generation
03/01/2007US20070049761 Substituted phosphonate fluorescent sensors and use thereof
03/01/2007US20070049754 Phosphonate analogs of HIV inhibitor compounds
03/01/2007US20070049718 Method for producing phosphonate-modified silicones
03/01/2007US20070049558 New Spirotricyclic Derivatives and Their Use as Phosphodiesterase-7 Inhibitors
03/01/2007US20070049542 exposing the bacterial cells to a growth-inhibiting amount of an antisense oligonucleotide compound, composed of morpholino subunits and phosphorus-containing intersubunit linkages joining a morpholino nitrogen of one subunit to a 5' exocyclic carbon of an adjacent subunit; Escherichia coli, Salmonella
03/01/2007US20070049519 Bactericides with antibacterial activity and an improved mammalian safety profile; exhibit reduced tissue accumulation and/or nephrotoxicity when administered to mammals
03/01/2007CA2606879A1 Process of making geminal bisphosphonic acids and pharmaceutically acceptable salts and/or hydrates thereof
1 ... 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 ... 554